HALEON PLC-ADR (HLN) Fundamental Analysis & Valuation

NYSE:HLN • US4055521003

Current stock price

10.431 USD
+0.4 (+4%)
Last:

This HLN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. HLN Profitability Analysis

1.1 Basic Checks

  • HLN had positive earnings in the past year.
  • In the past year HLN had a positive cash flow from operations.
  • In the past 5 years HLN has always been profitable.
  • Each year in the past 5 years HLN had a positive operating cash flow.
HLN Yearly Net Income VS EBIT VS OCF VS FCFHLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.11%, HLN belongs to the top of the industry, outperforming 86.46% of the companies in the same industry.
  • With an excellent Return On Equity value of 10.15%, HLN belongs to the best of the industry, outperforming 85.42% of the companies in the same industry.
  • HLN's Return On Invested Capital of 6.91% is amongst the best of the industry. HLN outperforms 84.38% of its industry peers.
Industry RankSector Rank
ROA 5.11%
ROE 10.15%
ROIC 6.91%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HLN Yearly ROA, ROE, ROICHLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

1.3 Margins

  • HLN has a better Profit Margin (15.11%) than 88.02% of its industry peers.
  • In the last couple of years the Profit Margin of HLN has grown nicely.
  • HLN has a Operating Margin of 22.36%. This is amongst the best in the industry. HLN outperforms 89.58% of its industry peers.
  • HLN's Operating Margin has been stable in the last couple of years.
  • With a decent Gross Margin value of 64.69%, HLN is doing good in the industry, outperforming 73.44% of the companies in the same industry.
  • In the last couple of years the Gross Margin of HLN has remained more or less at the same level.
Industry RankSector Rank
OM 22.36%
PM (TTM) 15.11%
GM 64.69%
OM growth 3Y-0.1%
OM growth 5Y0.08%
PM growth 3Y15.68%
PM growth 5Y5.48%
GM growth 3Y1.46%
GM growth 5Y0.97%
HLN Yearly Profit, Operating, Gross MarginsHLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. HLN Health Analysis

2.1 Basic Checks

  • HLN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • HLN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HLN Yearly Shares OutstandingHLN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
HLN Yearly Total Debt VS Total AssetsHLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 2.52 indicates that HLN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.52, HLN is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • The Debt to FCF ratio of HLN is 3.88, which is a good value as it means it would take HLN, 3.88 years of fcf income to pay off all of its debts.
  • HLN's Debt to FCF ratio of 3.88 is amongst the best of the industry. HLN outperforms 88.02% of its industry peers.
  • HLN has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.47, HLN is not doing good in the industry: 61.46% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.88
Altman-Z 2.52
ROIC/WACC0.73
WACC9.47%
HLN Yearly LT Debt VS Equity VS FCFHLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

  • A Current Ratio of 0.92 indicates that HLN may have some problems paying its short term obligations.
  • With a Current ratio value of 0.92, HLN is not doing good in the industry: 85.42% of the companies in the same industry are doing better.
  • HLN has a Quick Ratio of 0.92. This is a bad value and indicates that HLN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HLN has a Quick ratio of 0.71. This is amonst the worse of the industry: HLN underperforms 84.38% of its industry peers.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.71
HLN Yearly Current Assets VS Current LiabilitesHLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. HLN Growth Analysis

3.1 Past

  • HLN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.59%.
  • Measured over the past years, HLN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.56% on average per year.
  • Looking at the last year, HLN shows a decrease in Revenue. The Revenue has decreased by -0.61% in the last year.
  • The Revenue has been growing slightly by 5.78% on average over the past years.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%281.35%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-0.29%

3.2 Future

  • HLN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.38% yearly.
  • Based on estimates for the next years, HLN will show a small growth in Revenue. The Revenue will grow by 3.26% on average per year.
EPS Next Y6.33%
EPS Next 2Y8.54%
EPS Next 3Y8.95%
EPS Next 5Y7.38%
Revenue Next Year-1.37%
Revenue Next 2Y1.08%
Revenue Next 3Y2.23%
Revenue Next 5Y3.26%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HLN Yearly Revenue VS EstimatesHLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
HLN Yearly EPS VS EstimatesHLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.1 0.2 0.3 0.4 0.5

More info and screens

Find the best growth stocksShow best growing peers

6

4. HLN Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 21.73, HLN is valued on the expensive side.
  • HLN's Price/Earnings ratio is rather cheap when compared to the industry. HLN is cheaper than 81.77% of the companies in the same industry.
  • HLN's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.71.
  • HLN is valuated rather expensively with a Price/Forward Earnings ratio of 18.53.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of HLN indicates a rather cheap valuation: HLN is cheaper than 80.21% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of HLN to the average of the S&P500 Index (23.83), we can say HLN is valued slightly cheaper.
Industry RankSector Rank
PE 21.73
Fwd PE 18.53
HLN Price Earnings VS Forward Price EarningsHLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • HLN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. HLN is cheaper than 82.81% of the companies in the same industry.
  • 86.98% of the companies in the same industry are more expensive than HLN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.76
EV/EBITDA 14.49
HLN Per share dataHLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HLN does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of HLN may justify a higher PE ratio.
PEG (NY)3.43
PEG (5Y)1.24
EPS Next 2Y8.54%
EPS Next 3Y8.95%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. HLN Dividend Analysis

5.1 Amount

  • HLN has a Yearly Dividend Yield of 1.90%. Purely for dividend investing, there may be better candidates out there.
  • HLN's Dividend Yield is rather good when compared to the industry average which is at 0.77. HLN pays more dividend than 92.19% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.91, HLN has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.9%

5.2 History

  • HLN has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of HLN decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
HLN Yearly Dividends per shareHLN Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.05 0.1 0.15 0.2

5.3 Sustainability

  • HLN pays out 36.71% of its income as dividend. This is a sustainable payout ratio.
DP36.71%
EPS Next 2Y8.54%
EPS Next 3Y8.95%
HLN Yearly Income VS Free CF VS DividendHLN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
HLN Dividend Payout.HLN Dividend Payout, showing the Payout Ratio.HLN Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

HLN Fundamentals: All Metrics, Ratios and Statistics

HALEON PLC-ADR

NYSE:HLN (3/16/2026, 3:05:08 PM)

10.431

+0.4 (+4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-25
Earnings (Next)04-29
Inst Owners60.22%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap46.45B
Revenue(TTM)11.23B
Net Income(TTM)1.67B
Analysts80
Price Target11.91 (14.18%)
Short Float %0.38%
Short Ratio2.01
Dividend
Industry RankSector Rank
Dividend Yield 1.9%
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP36.71%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-10
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.73%
Min Revenue beat(2)-3.78%
Max Revenue beat(2)-1.69%
Revenue beat(4)0
Avg Revenue beat(4)-3.44%
Min Revenue beat(4)-4.82%
Max Revenue beat(4)-1.69%
Revenue beat(8)0
Avg Revenue beat(8)-3.28%
Revenue beat(12)1
Avg Revenue beat(12)-2.85%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.16%
PT rev (3m)4.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.98%
EPS NY rev (3m)-1.41%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.08%
Revenue NY rev (3m)-1.08%
Valuation
Industry RankSector Rank
PE 21.73
Fwd PE 18.53
P/S 3.17
P/FCF 15.76
P/OCF 13.29
P/B 2.13
P/tB N/A
EV/EBITDA 14.49
EPS(TTM)0.48
EY4.6%
EPS(NY)0.56
Fwd EY5.4%
FCF(TTM)0.66
FCFY6.34%
OCF(TTM)0.78
OCFY7.52%
SpS3.29
BVpS4.89
TBVpS-2.74
PEG (NY)3.43
PEG (5Y)1.24
Graham Number7.27
Profitability
Industry RankSector Rank
ROA 5.11%
ROE 10.15%
ROCE 8.9%
ROIC 6.91%
ROICexc 7.26%
ROICexgc 251.94%
OM 22.36%
PM (TTM) 15.11%
GM 64.69%
FCFM 20.14%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.1%
OM growth 5Y0.08%
PM growth 3Y15.68%
PM growth 5Y5.48%
GM growth 3Y1.46%
GM growth 5Y0.97%
F-Score8
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.88
Debt/EBITDA 2.75
Cap/Depr 114.72%
Cap/Sales 3.74%
Interest Coverage 6.91
Cash Conversion 93.21%
Profit Quality 133.23%
Current Ratio 0.92
Quick Ratio 0.71
Altman-Z 2.52
F-Score8
WACC9.47%
ROIC/WACC0.73
Cap/Depr(3y)107.2%
Cap/Depr(5y)109.42%
Cap/Sales(3y)3.18%
Cap/Sales(5y)3.14%
Profit Quality(3y)146.3%
Profit Quality(5y)135.74%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%281.35%
EPS Next Y6.33%
EPS Next 2Y8.54%
EPS Next 3Y8.95%
EPS Next 5Y7.38%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-0.29%
Revenue Next Year-1.37%
Revenue Next 2Y1.08%
Revenue Next 3Y2.23%
Revenue Next 5Y3.26%
EBIT growth 1Y-3.1%
EBIT growth 3Y0.42%
EBIT growth 5Y2.28%
EBIT Next Year20.78%
EBIT Next 3Y10.91%
EBIT Next 5Y9.2%
FCF growth 1Y12%
FCF growth 3Y8.58%
FCF growth 5Y15.32%
OCF growth 1Y14.47%
OCF growth 3Y8.49%
OCF growth 5Y13.36%

HALEON PLC-ADR / HLN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HALEON PLC-ADR?

ChartMill assigns a fundamental rating of 5 / 10 to HLN.


Can you provide the valuation status for HALEON PLC-ADR?

ChartMill assigns a valuation rating of 6 / 10 to HALEON PLC-ADR (HLN). This can be considered as Fairly Valued.


How profitable is HALEON PLC-ADR (HLN) stock?

HALEON PLC-ADR (HLN) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for HLN stock?

The Price/Earnings (PE) ratio for HALEON PLC-ADR (HLN) is 21.73 and the Price/Book (PB) ratio is 2.13.


Can you provide the dividend sustainability for HLN stock?

The dividend rating of HALEON PLC-ADR (HLN) is 5 / 10 and the dividend payout ratio is 36.71%.